Provided by Tiger Trade Technology Pte. Ltd.

Harrow Health Inc

37.55
-0.3000-0.79%
Volume:354.69K
Turnover:13.37M
Market Cap:1.41B
PE:-37.58
High:38.00
Open:37.92
Low:37.40
Close:37.85
52wk High:54.85
52wk Low:28.54
Shares:37.49M
Float Shares:28.93M
Volume Ratio:0.87
T/O Rate:1.23%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9993
EPS(LYR):-0.1400
ROE:-116.07%
ROA:-0.45%
PB:92.61
PE(LYR):-268.21

Loading ...

Leerink Partners Initiates Coverage on Harrow With Outperform Rating, $45 Price Target

MT Newswires Live
·
Yesterday

Harrow initiated with an Outperform at Leerink

TIPRANKS
·
Yesterday

Harrow CFO Andrew Boll Takes on Principal Accounting Officer Role After Pollard Exit

Reuters
·
Sep 05

Harrow (HROW) Dropped, So What Is Behind The Latest Attention?

Simply Wall St.
·
Aug 28

Analysts’ Top NA Picks: Harrow Health (HROW), Boost Run (BRUN)

TIPRANKS
·
Aug 26

Analysts’ Top NA Picks: Harrow Health (HROW), Scribe Therapeutics Inc. (SCTX)

TIPRANKS
·
Aug 20

Analysts Have Conflicting Sentiments on These NA Companies: Harrow Health (HROW) and Lineage, Inc. (LINE)

TIPRANKS
·
Aug 20

Harrow's IHEEZO Cuts Patient-Reported Discomfort 58% in Intravitreal-Injection Study

MT Newswires Live
·
Aug 20

Harrow Announces Iheezo® Data in Patient-Reported Discomfort Following Intravitreal Injections

THOMSON REUTERS
·
Aug 20

Harrow: Single-Center, Investigator-Initiated Study Demonstrated Statistically Significant Differences Favoring Iheezo at Every Measured Time Point

THOMSON REUTERS
·
Aug 20

Harrow - Iheezo Associated with Lower Patient-Reported Discomfort at All Post-Injection Assessments

THOMSON REUTERS
·
Aug 20

Harrow Says Iheezo Trial Shows 58% Lower Discomfort than Proparacaine After Intravitreal Injections

Reuters
·
Aug 20

Harrow (HROW) Reaffirms 2026 Guidance, Is The Upside Already Priced In?

Simply Wall St.
·
Aug 20

Will Harrow’s (HROW) TYRVAYA Deal and Reaffirmed 2026 Guidance Redefine Its Dry Eye Strategy?

Simply Wall St.
·
Aug 18

Harrow Chief Scientific Officer Amir Shojaei Disposes of 11,250 Common Shares Worth $450,000

Reuters
·
Aug 18

Harrow Price Target Maintained with a $63.00/Share by BTIG

Dow Jones
·
Aug 12

Harrow, Inc. Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 11

Harrow Q2 Swings to Loss, Revenue Rises

MT Newswires Live
·
Aug 11

GUIDANCE: (HROW) Harrow Expects Full Year 2026 Revenue Range $350M - $365M, vs. FactSet Est of $348.5M

MT Newswires Live
·
Aug 11

Earnings Flash (HROW) Harrow Posts Q2 Loss $0.46, vs. FactSet Est of $0.18 Loss

MT Newswires Live
·
Aug 11